logo

CRYOLIFE I(NYSE:CRY)
CryoLife, Inc. is the leader in the development and commercialization of implantable living human tissues for use in cardiovascular, vascular, and orthopaedic surgeries throughout the United States and Canada. The company''s BioGlue surgical adhesive, the company marked in the European Union for use in vascular and pulmonary sealing and repair, is distributed throughout Europe. The company also manufactures CryoLife- O''Brien and CryoLife-Ross stentless porcine heart valves which are distributed within the European Community. (PRESS RELEASE)
# Employees: 435
Address: 1655 Roberts Boulevard N.W.,Kennesaw,GA,USA
Phone: 770 419-3355
Fax: 770 426-0031
Website: www.cryolife.com
Email: info@cryolife.com
Sector: Medical
Industry: MED PRODUCTS
Executive Officers
Steven G. Anderson (Chmn.; Presi.; C.E.O.)
Ashley D. Lee (Exec. V.P.; C.O.O.; C.F.O.)
Amy D. Horton (C.A.O.)
Thomas F. Ackerman (Dir.)
James S. Benson (Dir.,)
Dividend
Ex-Dividend Date: N/A
Annual Dividend: N/A
Current Dividend Yield: N/A
Dividend Paid (3 months): N/A
Indicated Dividend: N/A
Earnings
Last Earnings Date: 9/30/2009
Next Earnings Date(Expected): 2/18/2010
Mean EPS (Next Qtr): $0.08
Mean EPS (Year): $0.30
Mean Estimate(Long Term): ($0.01)
P/E Ratio(Based on EPS estimate): 20.370
Number of Estimates: 3
Shares Performance
Period CRY Compare to S&P
YTD -37.08 % -47.92 %
4 Weeks -15.37 % -16.29 %
12 Weeks -18.42 % -23.09 %
Shares Information
Analyst Coverage: Y
Avg Volume: 293161
Shares Outstanding: 28M
Market Cap: $0.17B
52 Week High: $9.89
52 Week Low: $4.00
P/E Ratio: 18.510
PEG Ratio: -0.010
Split: On 12/28/2000 CRY split by factor of 1.500
Earnings Performance
EPS Growth in Last Quarter: -22.22 %
EPS Growth in Last Year: -41.67 %
Sales Growth in Last Quarter: 0.20 %
Sales Growth in Last Quarter: 5.28 %
Financials
Qtr Book Value: $1.60
Cash Flow/Share: $9.97
Change in Payout Ratio: 0.000
Price/Sales: 1.600
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia